Item 1. | Security and Issuer. |
The class of equity security to which this statement on Schedule 13D relates is the Common Stock (“Common Stock”) of GreenLight Biosciences Holdings, PBC, a Delaware corporation. The address of the principal executive offices of GreenLight Biosciences Holdings, PBC is 200 Boston Avenue, Medford, Massachusetts 02155. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable.
Item 2. | Identity and Background. |
| (a) | This Schedule 13D is filed by Kodiak Venture Partners III, L.P. (“Kodiak III”), Kodiak III Entrepreneurs Fund, L.P. (“Kodiak III-E”), Kodiak Ventures Management III, L.P. (“Kodiak III GP”), and Kodiak Ventures Management (GP), LLC (“Kodiak GP-GP” and, with Kodiak III, Kodiak III-E and Kodiak III GP, collectively, the “Reporting Persons”). |
| (b) | The principal business address of the Reporting Persons is 11 Peter Grover Road, Bethel, Maine 04217. |
| (c) | The principal business of the Reporting Persons is venture capital investments. Kodiak GP-GP is the general partner of Kodiak III GP, and Kodiak III GP is the general partner of each of Kodiak III and Kodiak III-E. |
| (d) | During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). |
| (e) | During the last five years, none of the Reporting Persons was a party to a civil proceeding of a judicial of administrative body of competent jurisdiction or were subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
| (f) | Each of Kodiak III, Kodiak III-E, Kodiak III GP and Kodiak GP-GP was organized in the state of Delaware. |
In accordance with the provisions of General Instruction C to Schedule 13D, information concerning the Managers of Kodiak GP-GP required by Item 2 of Schedule 13D is listed on Schedule 1 hereto and is incorporated by reference herein.
Item 3. | Source and Amount of Funds or Other Consideration. |
Business Combination
Of the shares of Common Stock reported herein as beneficially owned by the Reporting Persons, an aggregate of 9,809,895 were acquired pursuant to the Business Combination Agreement, dated August 9, 2021 (the “Business Combination Agreement”) by and among Environmental Impact Acquisition Corp., a Delaware corporation (“ENVI”), Honey Bee Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and GreenLight Biosciences, Inc., a Delaware corporation (“Old GreenLight”). Pursuant to the terms of the Business Combination Agreement, Merger Sub merged with and into Old GreenLight, with Old GreenLight surviving the merger as a wholly-owned subsidiary of ENVI (the “Business Combination”). In connection with the consummation of the Business Combination on February 2, 2022 (the “Closing Date”), ENVI changed its name to GreenLight Biosciences Holdings, PBC (the “Issuer”).
As a result of the Business Combination and upon the Closing Date, each common share of Old GreenLight that was issued and outstanding immediately prior to the effective time of the Business Combination, after giving effect to the conversion of all preferred shares of Old GreenLight into common shares of Old GreenLight immediately prior to the effective time, was canceled and converted into the right to receive a number of shares of Common Stock of the Issuer equal to an exchange ratio of 0.6656 multiplied by the number of common shares of Old GreenLight held by such holder immediately prior to the effective time.